Attachment device and methods of using the same

Information

  • Patent Grant
  • 8603161
  • Patent Number
    8,603,161
  • Date Filed
    Monday, July 6, 2009
    14 years ago
  • Date Issued
    Tuesday, December 10, 2013
    10 years ago
Abstract
Devices for attaching a first mass and a second mass and methods of making and using the same are disclosed. The devices can be made from an resilient, elastic or deformable materials. The devices can be used to attach a heart valve ring to a biological annulus. The devices can also be used for wound closure or a variety of other procedures such as anchoring a prosthesis to surrounding tissue or another prosthesis, tissue repair, such as in the closure of congenital defects such as septal heart defects, tissue or vessel anastomosis, fixation of tissue with or without a reinforcing mesh for hernia repair, orthopedic anchoring such as in bone fusing or tendon or muscle repair, ophthalmic indications, laparoscopic or endoscopic tissue repair or placement of prostheses, or use by robotic devices for procedures such as those above performed remotely.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates generally to a device for attaching a first mass to a second mass and methods of making and using the same.


2. Description of the Related Art


Prosthetic heart valves can replace defective human valves in patients. Prosthetic valves commonly include sewing rings, suture cuffs or rings that are attached to and extend around the outer circumference of the prosthetic valve orifice.


In a typical prosthetic valve implantation procedure, the aorta is incised and the defective valve is removed leaving the desired placement site that may include a fibrous tissue layer or annular tissue. Known heart valve replacement techniques include individually passing sutures through the fibrous tissue or desired placement site within the valve annulus to form an array of sutures. Free ends of the sutures are extended out of the thoracic cavity and laid, spaced apart, on the patient's body. The free ends of the sutures are then individually threaded through a flange of the sewing ring. Once all sutures have been run through the sewing ring (typically 12 to 18 sutures), all the sutures are pulled up taught and the prosthetic valve is slid or “parachuted” down into place adjacent the placement site tissue. The prosthetic valve is then secured in place by traditional knot tying with the sutures. This procedure is time consuming as doctors often use three to ten knots per suture.


The sewing ring is often made of a biocompatible fabric through which a needle and suture can pass. The prosthetic valves are typically attached to the sewing rings which are sutured to a biological mass that is left when the surgeon removes the existing valve from the patient's heart. The sutures are tied snugly, thereby securing the sewing ring to the biological mass and, in turn, the prosthetic valve to the heart.


During heart valve replacement procedures, the patient is on heart-lung bypass which reduces the patient's oxygen level and creates non-physiological blood flow dynamics. The longer a patient is on heat-lung bypass, the greater the risk for permanent health damage. Existing suturing techniques extend the duration of bypass and increase the health risks due to heart-lung bypass. Furthermore, the fixturing force created by suturing varies significantly from suture to suture, even for the same medical professional.


In addition, sutures and other attachment devices are used in a variety of medical applications where the use of the device of the present invention would provide an advantage in fixing a first mass to a second mass, where the first mass is a tissue or a device or prosthesis, and the second mass is a tissue or a device or prosthesis. These applications include anchoring a prosthesis such as a synthetic or autologous graft to surrounding tissue or another prosthesis, tissue repair such as in the closure of congenital defects such as septal heart defects, tissue or vessel anastomosis, fixation of tissue with or without a reinforcing mesh for hernia repair, orthopedic anchoring such as in bone fusing or tendon or muscle repair, ophthalmic indications, laparoscopic or endoscopic tissue repair or placement of prostheses, or use by robotic devices for procedures performed remotely.


For these indications and others, there is a need for a fixturing device to minimize the time spent fixturing certain devices or conduits, such as a valve prosthesis and a second mass, a vessel to another vessel or anatomical structure, tissue to tissue, surrounding tissue to a second prosthesis, and the like as described above. Furthermore, there is a need for a device that compliments existing suturing or attachment devices and methods and reduces fixturing times. Also, there is a need for a fixturing device that can be easily removed. There also exist a need to provide a fixturing device that can provide a consistent fixturing force.


BRIEF SUMMARY OF THE INVENTION

A device for connecting a first mass to a second mass is disclosed. The device has a base and a first leg. The base has a base axis, a first end and a second end. The first leg extends from the first end of the base. The device has a first configuration and a second configuration. When the base is rotated with respect to the base axis, the device is in the first configuration. The device can also have a second leg extending from the second end of the base.


Another device for connecting a first mass to a second mass is disclosed. The device has a base, a first leg and a second leg. The base has a base axis, a first end and a second end. The first leg has a first longitudinal axis and a first leg length. The first leg extends from the first end of the base. The second leg has a second longitudinal axis and a second leg length. The second leg extends from the second end of the base. The first leg length is substantially longer than the second leg length.


The device can have a first configuration and a second configuration. When the base is rotated with respect to the base axis, the device is in the first configuration.


Yet another device for connecting a first mass to a second mass is disclosed. The device has a base, a first leg and a second leg. The base is curved. The base has a base diameter, a first end and a second end. The first leg has a first longitudinal axis and a first leg length. The first leg extends from the first end of the base. The second leg has a second longitudinal axis and a second leg length. The second leg extends from the second end of the base. The device has a relaxed configuration. In the relaxed configuration the first leg crosses the second leg at a leg angle. The leg angle is less than 180 degrees.


The leg angle can be less than or equal to 90 degrees. The leg angle can be less than or equal to 60 degrees. The base diameter can be less than or equal to 0.13 inches. The base diameter can be greater than or equal to 0.08 inches.


A method of attaching a first mass to a second mass is disclosed. The method uses an attachment device having a base, a first leg, and a second leg. The base has a first end and a second end. The first leg extends from the first end of the base. The second leg extends from the second end of the base. The attachment device has a first configuration and a second configuration. The method includes holding the attachment device in the first configuration. The method also includes twisting the base of the attachment device to force the attachment device into the second configuration. Further, the method includes inserting the attachment device into the first mass and the second mass. The method also includes releasing the attachment device.


Twisting the base of the attachment device can occur before inserting the attachment device into the first mass. Inserting the attachment device, at least partially, into the first mass can occur before twisting the base of the attachment device.


Another method of attaching a first mass to a second mass is disclosed. The method includes forcibly holding an attachment device in a second configuration. The attachment device has a first configuration and the second configuration. The method also includes inserting the attachment device into the first mass and the second mass. The method also includes releasing the attachment device into the first configuration.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a front view of an embodiment of the attachment device.



FIG. 2 is a side view of an embodiment of the attachment device.



FIG. 3 is a bottom view of an embodiment of the attachment device.



FIGS. 4-10 illustrate embodiments of section A-A of the attachment device.



FIG. 11 is a front view of an embodiment of the attachment device.



FIGS. 12 and 13 are bottom views of various embodiments of the attachment device shown in FIG. 11.



FIGS. 14 and 15 are front views of various embodiments of the attachment device.



FIG. 16 is a front perspective view of an embodiment of the attachment device.



FIG. 17 is a top view of the embodiment of the attachment device shown in FIG. 16.



FIG. 18 is a side perspective view of an embodiment of the attachment device.



FIG. 19 is a side view of the attachment device shown in FIG. 18.



FIGS. 20 and 21 are front views of various embodiments of the attachment device.



FIG. 22 is a front perspective view of an embodiment of the attachment device.



FIG. 23 is a top view of the embodiment of the attachment device shown in FIG. 22.



FIG. 24 is a front view of an embodiment of the attachment device.



FIG. 25 illustrates an embodiment of a mandrel for manufacturing the attachment device.



FIGS. 26 and 27 illustrate methods of changing the attachment device from a first configuration to a second configuration.



FIGS. 28-30 are cross-sections illustrating an embodiment of a method of using the attachment device.



FIGS. 31-33 are cross-sections illustrating an embodiment of a method of using the attachment device with the pledget shown in full perspective for FIGS. 31 and 32.



FIGS. 34-36 are cross-sections illustrating an embodiment of a method of using the embodiment of the attachment device shown in FIG. 14.



FIGS. 37-39 are cross-sections illustrating an embodiment of a method of using the embodiment of the attachment device shown in FIGS. 18 and 19.



FIGS. 40-42 are cross-sections illustrating an embodiment of a method of using the attachment device.



FIG. 43 is a cross-section illustrating a method of using the flag.



FIG. 44 illustrates an embodiment of the tool for deploying the attachment device.



FIG. 45 illustrates the end of a tool for deploying the attachment device.



FIGS. 46 and 47 illustrate using the tip of an embodiment of the tool to deploy the attachment device.





DETAILED DESCRIPTION


FIGS. 1 through 3 illustrate an attachment device 2. The attachment device 2 can have a base 4, legs 6, and a tip 8 at the end of each leg 6. (Phantom lines delineate the base 4, legs 6 and tips 8.) The base 4, legs 6 and tips 8 can be separate or integral elements. A flag 10 can be attached to, and extend from, the base 4. The base 4 and/or the legs 6 can be straight or curved.


The attachment device 2 can be made from a deformable or elastic material or a combination of materials having resulting deformable or elastic properties. The material can be, for example, stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY® from Elgin Specialty Metals, Elgin, Ill.; CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.), polymers such as polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ether ketone (PEEK), nylon, polyether-block co-polyamide polymers (e.g., PEBAX® from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX® from Thermedics Polymer Products, Wilmington, Mass.), polyvinyl chloride (PVC), polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), extruded collagen, silicone, echogenic, radioactive, radiopaque materials or combinations thereof Examples of radiopaque materials are barium sulfate, titanium, stainless steel, nickel-titanium alloys, tantalum and gold.


Any or all elements of the attachment device 2 can be a matrix for cell ingrowth or used with a fabric, for example a covering (not shown) that acts as a matrix for cell ingrowth. The fabric can be, for example, polyester (e.g., DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof.


The attachment device 2 and/or the fabric can be filled and/or coated with an agent delivery matrix known to one having ordinary skill in the art and/or a therapeutic and/or diagnostic agent. These agents can include radioactive materials; radiopaque materials; cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene; anti-inflammatory agents, for example non-steroidal anti-inflammatories (NSAIDs) such as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example ASPIRIN® from Bayer AG, Leverkusen, Germany; ibuprofen, for example ADVIL® from Wyeth, Collegeville, Pa.; indomethacin; mefenamic acid), COX-2 inhibitors (e.g., VIOXX® from Merck & Co., Inc., Whitehouse Station, N.J.; CELEBREX® from Pharmacia Corp., Peapack, N.J.; COX-1 inhibitors); immunosuppressive agents, for example Sirolimus (RAPAMUNE®, from Wyeth, Collegeville, Pa.), or matrix metalloproteinase (MMP) inhibitors (e.g., tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other agents are provided in Walton et al, Inhibition of Prostoglandin E2 Synthesis in Abdominal Aortic Aneurysms, Circulation, Jul. 6, 1999, 48-54; Tambiah et al, Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae, Brit. J. Surgery 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit. J. Surgery 86 (6), 771-775; Xu et al, Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589; and Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms, J. Clinical Investigation 105 (11), 1641-1649 which are all incorporated by reference in their entireties.


A base axis 12 can extend longitudinally through the transverse cross-sectional center of the base 4. As shown in FIG. 2, when viewed from the side, the base axis 12 can form a base plane angle 14 from about 0° to about 30°, for example about 10°. The base 4 can have a base inner radius 16 from about 0.25 mm (0.010 in.) to about 19.1 mm (0.750 in.), for example about 1.91 mm (0.075 in.). The proximal end of the base 4 can be formed into a table 17. The table 17 can be a flat surface that tapers to the base 4.


The base 4 and legs 6 can have a shaft diameter 18 from about 0.03 mm (0.001 in.) to about 6.35 mm (0.250 in.), for example, about 0.51 mm (0.020 in.). The base 4 and legs 6 can have the same or different shaft diameters 18. A base neutral radius 19 can be the base inner radius 16 and half the shaft diameter 18. As shown in FIG. 1, the legs 6 can intersect at a leg angle 20 in or near the plane of the attachment device 2 or in or near the approximate plane of the base 4. An approximate plane is a plane that can be used whether the base 4 does or does not fall on a flat plane. If the base 4 is a straight line or a point, the approximate plane of the base 4 can be calculated using the points of the legs 6 that are nearest the base 4 and out of line with the base 4. The leg angle 20 can be from about 180° to about 10°, more narrowly from about 90° to about 60°, for example about 45° or, for example, about 60°.


The length from an end of the base 4 to a longitudinal leg axis 24 can be a body length 22. The body length 22 can be from about 0.25 mm (0.010 in.) to about 12.7 mm (0.500 in.), for example about 2.913 mm (0.1147 in.). The length between the distal end of one tip 8 and the distal end of the opposite tip 8 can be a tip distance 26. The tip distance 26 can be from about 0.03 mm (0.001 in.) to about 25.4 mm (1.000 in.), more narrowly about 1.3 mm (0.050 in.) to about 3.18 mm (0.125 in.), for example about 2.3 mm (0.090 in.).


The tip 8 can have a tip length 28 from about 0.05 mm (0.002 in.) to about 12.7 mm (0.500 in.), for example about 1.0 mm (0.040 in.). The tip 8 can have a tip angle 30 from about 5° to about 90°, for example about 30°. The tips 8 can be straight, pointed ends, curve out of line (shown by alternative tips 8a and 8b, drawn in phantom lines in FIGS. 2 and 3) from the nearest end of the leg 6, or combinations thereof.


The tips 8 and/or legs 6 can have retention devices 29. The retention devices 29 can be barbs, spikes, hooks, threads, ribs, splines, a roughened surface, a sintered surface, a covered surface (e.g., with DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del.) or combinations thereof A retention coating 31, for example a biodegradable coating or filler such as gel or gelatin or otherwise removable, can be on and/or around and/or near the retention devices 29. The retention coating 31 (shown in phantom lines) can be configured to render the retention device 29 substantially ineffective until a substantial amount of the retention coating 31 has been biodegraded or otherwise removed.


The legs 6 can have mechanical interfaces 33, for example, a slot, snap, protrusion, latch, catch or combinations thereof The interfaces 33 can be aligned so the interface on one leg 6 meets the interface 33 on the other leg 6 at the point where the legs 6 cross. The interfaces 33 can removably attach to each other.



FIGS. 4 through 10 illustrate examples of cross-section A-A of the legs 6 and/or the base 4. The cross-section A-A of the legs 6 can be the same or different as the cross-sections of the base 4. The cross-sections of the base 4 and/or legs 6 can be constant or vary along their respective lengths. FIGS. 4 through 8, respectively, illustrate circular, rectangular (including square), triangular, substantially flat, and star-shaped or irregular cross-sections A-A. FIG. 9 illustrates an oval cross-section A-A. A ratio of the shaft diameter 18 to the length of a minor axis 32 can be from about 1:1 to about 20:1, for example 10:1.



FIG. 10 illustrates a cavity 36 inside the cross-section A-A. The cavity 34 can be hollow or can be filled completely or partially. The cavity 34 can be filled with an agent delivery matrix known to one having ordinary skill in the art and/or a therapeutic and/or diagnostic agent and/or echogenic and/or radioactive and/or radiopaque materials, for example, the agents and/or materials listed supra. The type and amount of filling can vary along the length of the base 4 and/or legs 6. The ratio of the shaft diameter 18 to a cavity diameter 36 can be from about 1:1 to about 50:1, for example, about 2:1.



FIG. 11 illustrates an attachment device 2 that can have a leg 6 that can have a first leg segment 38 and a second leg segment 40. The first leg segment 38 can extends from the base 4. The second leg segment 40 can extend on a proximal end from the first leg segment 38. The tip 8 can extend from a distal end of the second leg segment 40. The second leg segment 40 can have a different radius of curvature than the first leg segment 38 and/or form an angle with respect to the first leg segment 40. FIG. 12 illustrates that the second leg segment 40 can form an angle (shown by arrows) with the approximate plane of the base 4. FIG. 13 illustrates that the first leg segment 38 can form an angle (shown by arrows) with the approximate plane of the base 4. The second leg segments 40 can be substantially parallel with the approximate plan of the base 4.



FIG. 14 illustrates an attachment device 2 that can have a first leg 6a that can be substantially longer than a second leg 6b. The ratio of a first leg-tip length 22a to a second leg-tip length 22b can be from about 1:1 to about 10:1, for example, about 3:1.



FIG. 15 illustrates an attachment device that can have a first leg radius 42 and a second leg radius 44. The ratio of the first leg radius 42 to the second leg radius 44 can be from about 1:1 to about 50:1, for example about 10:1.



FIGS. 16 and 17 illustrate an attachment device 2 that can have a “flat top.” The approximate plane of the second leg 6b can form an angle, for example about 90°, with the approximate plane of the base 4. When in use, the flat top can further anchor the attachment device 2 against the first mass and/or second mass. FIGS. 18 and 19 illustrate an attachment device 2 that can have arms 6 that can wrap around the base axis 12.



FIG. 20 illustrates an attachment device 2 that can have arms 46 that can extend from the base 4 and/or the legs 6. When deployed, the arms 46 can squeeze tissue between the arms 46 and the legs 6 and/or base 4 for additional retention force. Anchors 48 can extend from the arms 46, for example at the distal ends of the arms 46. The anchors 48 can be, for example, hooks, barbs, spikes, staples or combinations thereof The anchors 48 can extend directly from the base 4 and/or legs 6 with or without arms 46 separately attached to the base 4 and/or legs 6. FIG. 21 illustrates an attachment device 2 that can have a straight base 4 and can have the arms 46 extending from the base 4.



FIGS. 22 and 23 illustrate an attachment device that can have first, second and third legs 6a, 6b and 6c. The base 4 can be a platform, wireframe, or point attachment which can be spot-welded or brazed, tube crimped or otherwise mechanically connected. The planes of the legs 6a, 6b and 6c can intersect at substantially equal angles, about 120°, or unequal angles.



FIG. 24 illustrates an attachment device that can have a first loop 49 and a second loop 51. The first loop 49 can be formed from the base 4 and a proximal portion of the first leg segments 38. The second loop 51 can be formed from a distal portion of the first leg segments 38 and a proximal portion of the second leg segments 40.


Methods of Making



FIG. 25 illustrates a mandrel 50 that can be used to form the attachment device 2, for example during heat treatment. The base 4 and/or legs 6 can be held on the mandrel 50 by a single cylinder 52, a formed path 54, a pressure plate 56, for example a washer under a screw or combinations thereof Methods for forming shape memory alloys (e.g., Nitinol) are known to those having ordinary skill in the art. The tips 8 can be formed, for example, by grinding, electropolishing, or precision sharpening (e.g., polishing services from Point Technologies, Inc., Boulder, Colo.) to a satisfactory geometry, including a trocar point, beveled, rounded, tapered, pointed or flattened.


Other methods known to one having ordinary skill in the art can be used to manufacture the attachment device 2 and/or its elements. For example, manufacturing techniques include molding, machining, casting, forming (e.g., pressure forming), crimping, stamping, melting, screwing, gluing, welding, die cutting, laser cutting, electrical discharge machining (EDM), etching or combinations thereof.


Any elements, sub-assemblies, or the attachment device 2 as a whole after final assembly, can be coated by dip-coating or spray-coating methods known to one having ordinary skill in the art, utilizing materials such as PTFE (e.g., TEFLON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), polyester (e.g., DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), gelatin, gel, other polymers or combinations thereof One example of a method used to coat a medical device for vascular use is provided in U.S. Pat. No. 6,358,556 by Ding et al. and hereby incorporated by reference in its entirety. Time release coating methods known to one having ordinary skill in the art can also be used to delay the release of an agent in the coating. The coatings can be thrombogenic or anti-thrombogenic.


The attachment device 2, or any element thereof (e.g., the base 4) can be covered with a fabric, for example polyester (e.g., DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE (e.g., TEFLON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), ePTFE, nylon, extruded collagen, gel, gelatin, silicone or combinations thereof Methods of covering an implantable device with fabric are known to those having ordinary skill in the art, for example, sintering, spray coating, adhesion, loose covering, dipping or combinations thereof.


Methods of Using


The attachment device 2 can have a first configuration (e.g., the configuration shown in FIGS. 26 and 27) and a second configuration (e.g., the configuration shown in FIGS. 1 through 3). The attachment device 2 can have the second configuration when the attachment device is in a relaxed state, with no external forces applied (e.g., prior to insertion or use). The attachment device 2 can have the first configuration when external forces are applied, such as by a delivery tool prior to delivery. When external forces are removed from the attachment device 2, the attachment device 2 can revert from the first configuration to the second configuration.


The attachment device can substantially revert to the second configuration even when some permanent hysteresis deformation occurs and/or when a foreign object (e.g., a first and/or second mass) is obstructing the attachment device 2. When the attachment device 2 has the first configuration, one or both legs 6 can be rotated with respect to the base 4 (e.g., by rotating the base 4 around the base axis 12, one or both legs 6 splay or separate as they are torqued by the twisting or rotating around of the base).



FIG. 26 illustrates a method of forcing the attachment device to have the first configuration. The attachment device 2 can be forced to have the first configuration by the application of a base torque, shown by arrows 58, applied about the base axis 12. The base torque can be directly applied to the base 4. The base torque indirectly becomes, or can be applied as, a leg torque, as shown by arrows 60a and 60b, to the legs 6a and/or 6b about the leg axes 24a and 24b. If approximately two times the base neutral radius 19 is less than the tip distance 26, the legs 6 will splay outward when entering the first mass 68. If approximately two times the base neutral radius 19 is greater than or equal to the tip distance 26, the legs 6 will splay inward or stay vertical when deploying into the first mass 68.



FIG. 27 illustrates a method of forcing the attachment device to have the first configuration. The attachment device 2 can be forced to have the first configuration by the application of a pivot torque, shown by arrows 62, applied about the area where the base 4 attaches to the legs 6, so that the legs 6 are forced to pivot radially outward from each other. The pivot torque can be applied by applying outward translational forces, as shown by arrows 64, to one or both legs 6. The pivot torque can be applied by applying translational forces to the base 4, as shown by arrows 66.


As illustrated in FIGS. 28 through 30, the attachment device 2 can be deployed to attach a first mass 68 to a second mass 70. The first mass 68 and/or the second mass 70 can be a prosthesis and/or a tissue, or both tissue or both prostheses. The prosthesis can be, for example, cardiac leads, markers, stents, grafts, stent-grafts, heart valves, annuloplasty rings, autografts, allografts, xenografts or any assemblies thereof or combination thereof The tissue can be, for example, vessels, valves, organs (e.g., intestine, heart, skin, liver, kidney, urethra, bone mass, tendon, nerve, muscle), calcified soft tissue or any combination thereof.


Heart valve assemblies disclosed by Griffin et al. in U.S. Pat. No. 6,241,765, by Lane in U.S. Pat. No. 6,371,983 and by Ritz in U.S. Pat. No. 5,976,183, both of which are hereby incorporated in their entireties, can be placed with the use of the device of the present invention. Other heart valve assemblies that can be used include, for example, the Advantage Bileaflet heart valve, Parallel valve, Freestyle stentless aortic valve, Hancock Porcine heart valve, Hancock apical left ventricular connector model 174A, Hancock valved conduit models 100, 105, 150, Hall Medtronic heart valve, Hall Medtronic valved conduit, MOSAIC® heart valve and Intact porcine tissue valve (by Medtronic, Inc. Minneapolis, Minn.); Angelini Lamina-flo valve (by Cardio Carbon Company, Ltd., England); Bjork-Shiley single-disk, monostrut and caged-disk valves (Shiley, Inc., now-defunct, previously of CA); Wada-Cutter valve and Chitra Cooley-Cutter valve (by Cutter Biomedical Corp., San Diego, Calif.); Angioflex trileaflet polyurethane valve (by Abiomed, Inc., Danvers, Mass.); ATS AP Series heart valve and ATS Standard heart valve (by ATS Medical, Inc., Minneapolis, Minn.); ANNULOFLO® annuloplasty ring, ANNUFLEX® annuloplasty ring, CARBSEAL® valved conduit, ORBIS® Universal aortic and mitral valve, pediatric/small adult valve, R series valve, SUMIT® mitral valve, TOP HAT® aortic valve, OPTIFORM® mitral valve, MITROFLOW SYNERGY® PC stented aortic pericardial bioprosthesis and the SYNERGY® ST stented aortic and mitral porcine bioprosthesis (by CarboMedics, Inc., Austin, Tex.); ON-X® prosthetic heart valve (by MCRI®, LLC, Austin, Tex.); Starr-Edwards SILASTIC® ball valve, Starr-Edwards 1000, Starr-Edwards 1200, Starr-Edwards 1260, Starr-Edwards 2400, Starr-Edwards 6300, Starr-Edwards 6500, Starr-Edwards 6520, Carpentier-Edwards porcine tissue valve, Carpentier-Edwards pericardial prosthesis, Carpentier-Edwards supra-annular valve, Carpentier-Edwards annuloplasty rings, Duromedics valve and PERIMOUNT® heart valve (by Edwards Lifesciences Corp., Irvine, Calif.); Cross-Jones Lenticular disc valve (by Pemco, Inc.); Tissuemed stented porcine valve (by Tissuemed, Ltd., Leeds, England); Tekna valve (by Baxter Healthcare, Corp., Deerfield, Ill.); Komp-01 mitral retainer ring (by Jyros Medical Ltd., London, England); SJM® Masters Series mechanical heart valve, SJM® Masters Series aortic valved graft prosthesis, ST. JUDE MEDICAL® mechanical heart valves, ST. JUDE MEDICAL® mechanical heart valve Hemodynamic Plus (HP) series, SJM REGENT® valve, TORONTO SPV® (Stentless Porcine Valve) valve, SJM BIOCOR® valve and SJM EPIC® valve (St. Jude Medical, Inc., St. Paul, Minn.); Sorin Bicarbon, Sorin Carbocast, Sorin Carboseal Conduit, Sorin Pericarbon and Sorin Pericarbon Stentless (by Snia S.p.A., Italy). The attachment devices of the present invention may be deployed to implant these various devices in the supra-annular position, or infrannular, depending on the geometry and preferred placement of a particular device. Similarly, it may be advantageous to use the attachment devices 2 of the present invention to secure a sewing ring, or first prosthesis by placing them horizontally or vertically within or around the annulus of such ring, prior to placing a second prosthesis including a valve structure, as provided in U.S. application Ser. No. 10/646,639 filed, 22 Aug. 2003, hereby incorporated by reference in its entirety.



FIG. 28 illustrates that the attachment device 2 can be held in the first configuration. The attachment device 2 can be fed through a pledget 71 before the attachment device 2 is forced into the first mass 68. The pledget 71 can be a piece of fabric, for example, a fabric listed supra. The pledget 71 can be loaded onto the attachment device 2 before use. FIG. 29 illustrates that the attachment device 2 can be forced, as shown by arrow 72, into and through the first mass 68 and part of the second mass 70. FIG. 30 illustrates that the attachment device 2 can be released from having the first configuration. The attachment device 2 can revert to having substantially the second configuration. A pinching force, shown by arrows, can be applied to the attachment device 2 to encourage additional reversion of the attachment device 2 to having the second configuration. The attachment device 2 shown in FIG. 24 can be deployed in the same manner as described supra, except that the attachment device 2 shown in FIG. 24 can be rotated sufficiently to straighten the first and second loops, before or during deployment.


The attachment device 2 can be removed and redeployed at any stage of deployment supra, for example, if the surgeon is unsatisfied with the position of the attachment device 2, or if the prosthesis need replacing or “redoing” at a point in the future. If the attachment device 2 has a retention device 29, when the retention coating 31 sufficiently biodegrades or is otherwise removed, the retention devices 29 will become exposed and can substantially prevent the removal of the attachment device 2 from the deployment site. Removal may still be achieved however, by apply sufficient force (by a tool or other device) to overcome the strength of the secondary retention element.



FIGS. 31 though 33 illustrate a method of deploying the attachment device 2 to attach a first mass 68 to a second mass 70. The pledget 71 can be fed over the attachment device 2 before use. The pledget 2 can be formed as a rectangular container with an access opening 73, for example a slit, hole, or aperture, to allow access to the base 4 of the attachment device 2. The attachment device 2 can have the second configuration. The attachment device 2 can be forced, as shown by arrow, so the tips 8 engage the first mass 68. FIG. 32 illustrates that, with the tips 8 held by the first mass 68, a longitudinal torque, shown by arrows, applied to the attachment device 2 about a longitudinal axis 74 can then force the attachment device 2 into the first configuration. As illustrated by FIG. 33, the attachment device 2 can be forced, shown by arrow, through the first mass 68 and part of the second mass 70. The longitudinal torque (not shown in FIG. 33) can be removed during deployment or after the attachment device 2 is completely deployed into the first and second masses 68 and 70. The pledget 71 can be crushed during deployment.



FIGS. 34 through 36 illustrate a method of deploying the attachment device shown in FIG. 14. The first leg 6a can be forced, as shown by arrow, into and through the first mass 68 and part of the second mass 70. The first leg 6a can have a “paddle” (not shown). The paddle can be a flat oval or long rectangular cross-sectional shape on one leg. The paddle can increase resistive force with the first and/or second mass 68 and/or 70 when applying torque to the attachment device 2.



FIG. 35 illustrates that the attachment device 2 can be forced into the first configuration by applying a base torque, shown by arrows 58. The second leg 6b can then rotate outwardly from the attachment device 2, as shown by arrow 76.



FIG. 36 illustrates that the attachment device 2 can be forced, shown by arrow, through the first mass 68 and part of the second mass 70. The base torque (not shown in FIG. 36) can be removed during deployment or after the attachment device 2 is completely deployed into the first and second masses 68 and 70.



FIGS. 37 through 39 illustrate a method of deploying the attachment device 2 shown in FIGS. 18 and 19. FIG. 37 illustrates that the base 4 and the tips 8 can be placed in contact with or near the first mass 68. FIG. 38 illustrates that the arms 6 can be rotated, as shown by arrows, about the base axis 12. The arms 6 can be rotated to cause the arms 6 to be forced into the first mass 68. FIG. 39 illustrates that the arms 6 can be rotated, as shown by arrows, further about the base axis 12. The arms 6 can be forced into and through the second mass 70. The arms 6 can re-enter the first mass 68.



FIGS. 40 through 42 illustrate a method of deploying the attachment device 2 to attach a first mass 68 to a second mass 70. The first mass 68 and the second mass 70 can be two sections of the same object, such as when the attachment device 2 is used to close a wound. FIG. 40 illustrates that the attachment device 2 can be held in the first configuration. FIG. 41 illustrates that the attachment device 2 can be forced, as shown by arrow 72, so that the first leg 6a inserts into the first mass 68 and that the second leg 6b inserts into the second mass 70. FIG. 42 illustrates that the attachment device 2 can be released from having the first configuration. The attachment device 2 can revert to having substantially the second configuration, causing the legs 6a and 6b to rotate inward, shown by arrows 78, applying force, shown by arrows 80, to the first mass 68 and the second mass 70 such that the first and second masses 68 and 70 move toward each other.


The attachment device 2 can be removed from the second mass 70 and/or the first mass 68, when applicable, by reversing the steps of the deployment methods supra.



FIG. 43 illustrates that, during use, the attachment device 2 can be covered by new tissue growth 82. The flag 10 can extend outside of the new tissue growth 82 (as shown) or be located just below the surface but palpable. The flag 10 can act as a marker, palpable or visible by direct vision or imaging modalities known in the art (e.g., x-ray, magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), echocardiogram) for example to locate the attachment device 2 in case of removal of the attachment device 2. The flag 10 can be made of, for example, suture material (e.g., Nylon, polyglycolic acid, polyester such as DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del., metals such as those used in the other elements of the attachment device 2, other polymers or combinations thereof). The base 4 can also serve this function (e.g., of a marker) in some applications.



FIG. 44 illustrates a tool 84 for deploying the attachment device 2. The tool 84 can have a first lever 86 and a second lever 88. The first lever 86 can be rotatably attached to the second lever 88 at a pivot 90. The first and second levers 86 and 88 can have a handle 92 at each lever's first end and a pad 94 at each lever's second end. The pads 94 can be used to hold the attachment device 2. When a force is applied to the handles 92, shown by arrows 96, the force is transmitted, shown by arrows 98, to the pads 94.


A driver shaft 100 can have a driver handle 102 at a first end and grips 104 at a second end. The pivot 90 can have a longitudinal channel 106. The driver shaft 100 can pass through the longitudinal channel 106 and/or be rotatably mounted to a case (not shown) fixed to a lever 86 or 88. The grips 104 can be releasably attached to the attachment device 2. The attachment device 2 can be rotated about the longitudinal axis 2 by releasing the pads 94 and rotating, as shown by arrows 108, the driver handle.



FIG. 45 shows the end of a tool 84 for deploying the attachment device 2 before the attachment device 2 has been loaded into the tool 84. The tool 84 can have a top part 110 and a bottom part 112. The top part 110 can be removably attached to the bottom part, as shown by arrow 114.


The top part 110 and/or the bottom part 112 can have grooves 116 sized to fit the base 4 and a portion of one or more legs 6 when the attachment device 2 has the first configuration. The attachment device 2 can be forced to have the first configuration and be loaded into the tool 84, as shown by arrow 118. The top part 110 can be attached to the bottom part 112 with the attachment device 2 seated (not shown) in the grooves 116.


The attachment device 2 can be placed at a desired deployment site by the tool 84. The device 2 can be deployed from the tool 84 by removing the top part 110 from the bottom part 112, and removing the tool 84 from the deployment site.



FIG. 46 illustrates an end of a tool 84. The tool 84 can have a case 120 with an anvil 122 and leg ports 124. The case 120 can be slidably attached to a slide 126. The attachment device 2 can be loaded around the anvil 122. The legs 6 can protrude from the case 120 through the leg ports 124.



FIG. 47 illustrates a method of using the tool 84 of FIG. 46 to deploy the attachment device 2. The slide 126 can be forced, as shown by arrow 128, toward the anvil 122. The slide 126 can push the base 4 against the anvil 122, causing the legs 6 to rotate outward, as shown by arrows 76. The surface geometry of the anvil 122 and the slider 126 can match the surface geometry of the attachment device 2, when the attachment device is fully strained, as shown in FIG. 39. The attachment device 2 can then be inserted into the desired deployment site (not shown). When the attachment device 2 is in place, the attachment device 2 can be deployed from the tool 84, for example, by sliding the anvil 122 out of the way (perpendicular to the plane of FIG. 47) and forcing the attachment device 2 out the end of the tool 84 with the slide 126.


The ends of the tools 84 shown in FIGS. 45 through 47 can be pivoted to the remainder of the tool 84 by methods known to those having ordinary skill in the art. The pivotable end of the tool 84 can improve access to deployment sites not as easily accessible by a non-articulating tool 84. The tool 84 can be non-articulatable. It would also be possible when access to the site of implantation allows, to employ a tool substantially similar to a needle driver tool known to those skilled in the art.


Additional disclosure is included in U.S. patent application Ser. Nos. 10/327,821 and 10/646,639, filed 20 Dec. 2002 and 22 Aug. 2003, respectively, which are hereby incorporated by reference in their entireties. It is apparent to one skilled in the art that various changes and modifications can be made to this disclosure, and equivalents employed, without departing from the spirit and scope of the invention. Elements shown with any embodiment are exemplary for the specific embodiment and can be used on other embodiments within this disclosure.

Claims
  • 1. A method for attaching a prosthesis to a tissue annulus using an attachment device comprising a base and a pair of legs extending from the base, the attachment device being elastically movable from a relaxed state wherein the legs cross one another and a delivery state wherein the legs extend substantially parallel with one another, the method comprising: loading the attachment device into a tool with the attachment device in the relaxed state;securing the prosthesis to the tissue annulus using the attachment device while applying a force using the tool to place the attachment device in the delivery state; andreleasing the attachment device from the tool such that the attachment device returns towards the relaxed state such that the legs cross one another,wherein the attachment device is delivered by:a) holding the attachment device in the tool in the relaxed state;b) applying a force with the tool to force the attachment device to the delivery state;c) inserting the legs through the prosthesis into tissue with the attachment device in the delivery state; andd) deploying the attachment device from the tool such that the attachment device returns towards the relaxed state.
  • 2. The method of claim 1, wherein the tool comprises an anvil, and step a) comprises loading the attachment device around the anvil in the relaxed state.
  • 3. The method of claim 1, wherein the tool comprises a slide and an anvil for causing the legs of the attachment device to rotate outward to the delivery state during step b).
  • 4. The method of claim 3, wherein step d) comprises sliding the anvil out of the way and forcing the attachment device out the end of the tool with the slide.
  • 5. The method of claim 1, wherein the tool retains the attachment device in the delivery state while the attachment device is inserted through the prosthesis into tissue, whereupon the attachment device is deployed from the tool.
  • 6. A method for attaching an annular prosthesis to a tissue annulus using a plurality of attachment devices, each attachment device comprising a base and a pair of legs extending from the base, the attachment device being elastically movable from a relaxed state wherein the legs cross one another and a delivery state wherein the legs extend substantially parallel with one another, the method comprising: loading an attachment device into a tool with the attachment device in the relaxed state;securing the annular prosthesis to the tissue annulus using the attachment device while applying a force using the tool to place the attachment device in the delivery state;releasing the attachment device from the tool such that the attachment device returns towards the relaxed state such that the legs cross one another; andinserting a plurality of additional attachment devices through the prosthesis and into the tissue annulus to further secure the annular prosthesis,wherein each attachment device is delivered by:a) holding the attachment device in the tool in the relaxed state;b) applying a force with the tool to force the attachment device to the delivery state;c) inserting the legs through the annular prosthesis into tissue with the attachment device in the delivery state; andd) deploying the attachment device from the tool such that the attachment device returns towards the relaxed state.
  • 7. The method of claim 6, wherein the annular prosthesis comprises one of a stent, graft, stent-graft, heart valve, annuloplasty ring, autograft, allograft, and a xenograft.
  • 8. The method of claim 6, wherein the annular prosthesis comprises a sewing ring, and wherein the annular prosthesis is attached to the tissue annulus by inserting the attachment devices through the sewing ring.
  • 9. The method of claim 6, wherein the tool comprises an anvil, and step a) comprises loading the attachment device around the anvil in the relaxed state.
  • 10. The method of claim 6, wherein the tool comprises a slide and an anvil for causing the legs of the attachment device to rotate outward to the delivery state during step b).
  • 11. The method of claim 10, wherein step d) comprises sliding the anvil out of the way and forcing the attachment device out the end of the tool with the slide.
  • 12. The method of claim 6, wherein the tool retains the attachment device in the delivery state while the attachment device is inserted through the annular prosthesis into tissue, whereupon the attachment device is deployed from the tool.
  • 13. A method for attaching a heart valve prosthesis to a tissue annulus using attachment devices, each attachment device comprising a base and a pair of legs extending from the base, the attachment devices being elastically movable from a relaxed state wherein the legs cross one another and a delivery state wherein the legs extend substantially parallel with one another, the heart valve prosthesis comprising a first prosthesis comprising a sewing ring and a second prosthesis comprising a valve structure, the method comprising: securing the first prosthesis to a tissue annulus by inserting the attachment devices through the sewing ring, a tool carrying the attachment devices in the relaxed state, the tool applying a force to place the attachment devices in the delivery state when the attachment devices are inserted through the sewing ring;releasing the attachment devices from the tool such that the attachment devices return towards the relaxed state such that the legs cross one another; andthereafter placing the second prosthesis,wherein each attachment device is delivered and released by:a) holding the attachment device in the tool in the relaxed state;b) applying a force with the tool to force the attachment device to the delivery state;c) inserting the legs through the first prosthesis into tissue with the attachment device in the delivery state; andd) deploying the attachment device from the tool such that the attachment device returns towards the relaxed state.
Parent Case Info

This application is a continuation of application Ser. No. 10/681,700, filed Oct. 8, 2003, now U.S. Pat. No. 7,556,647.

US Referenced Citations (604)
Number Name Date Kind
3143742 Cromie Aug 1964 A
3320974 High et al. May 1967 A
3370305 Goott et al. Feb 1968 A
3371352 Siposs Mar 1968 A
3409013 Berry Nov 1968 A
3464065 Cromie Sep 1969 A
3546710 Ivanovich et al. Dec 1970 A
3571815 Somyk Mar 1971 A
3574865 Hamaker Apr 1971 A
3628535 Ostrowsky et al. Dec 1971 A
3686740 Shiley Aug 1972 A
3691567 Cromie Sep 1972 A
3710744 Goodenough et al. Jan 1973 A
3744060 Bellhouse et al. Jul 1973 A
3755823 Hancock Sep 1973 A
3800403 Anderson Apr 1974 A
3839741 Haller Oct 1974 A
3959827 Kaster Jun 1976 A
3974854 Kurpanek Aug 1976 A
3996623 Kaster Dec 1976 A
3997923 Possis Dec 1976 A
4035849 Angell et al. Jul 1977 A
4078268 Possis Mar 1978 A
4078468 Civitello Mar 1978 A
4084268 Ionexcu et al. Apr 1978 A
4106129 Carpentier et al. Aug 1978 A
4164046 Cooley Aug 1979 A
4172295 Batten Oct 1979 A
4211325 Wright Jul 1980 A
4217665 Bex et al. Aug 1980 A
4218782 Rygg Aug 1980 A
4245358 Moasser Jan 1981 A
4259753 Liotta et al. Apr 1981 A
4291420 Reul Sep 1981 A
4297749 Davis et al. Nov 1981 A
RE30912 Hancock Apr 1982 E
4343048 Ross et al. Aug 1982 A
4364126 Rosen et al. Dec 1982 A
4388735 Ionescu et al. Jun 1983 A
4441216 Ionescu et al. Apr 1984 A
4451936 Carpentier et al. Jun 1984 A
4470157 Love Sep 1984 A
4477930 Totten et al. Oct 1984 A
4485816 Krumme Dec 1984 A
4501030 Lane Feb 1985 A
4506394 Bedard Mar 1985 A
4535483 Klawitter et al. Aug 1985 A
4548202 Duncan Oct 1985 A
4605407 Black et al. Aug 1986 A
4626255 Reichart et al. Dec 1986 A
4629459 Ionescu et al. Dec 1986 A
4665906 Jervis May 1987 A
4666442 Arru et al. May 1987 A
4680031 Alonso Jul 1987 A
4683883 Martin Aug 1987 A
4687483 Fisher et al. Aug 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4702250 Ovil et al. Oct 1987 A
4705516 Barone et al. Nov 1987 A
4725274 Lane et al. Feb 1988 A
4731074 Rousseau et al. Mar 1988 A
4743253 Magladry May 1988 A
4758151 Arru et al. Jul 1988 A
4775378 Knoch et al. Oct 1988 A
4778461 Pietsch et al. Oct 1988 A
4790843 Carpentier et al. Dec 1988 A
4816029 Penny, III et al. Mar 1989 A
4851000 Gupta Jul 1989 A
4865600 Carpentier et al. Sep 1989 A
4888009 Lederman et al. Dec 1989 A
4892541 Alonso Jan 1990 A
4917097 Proudian et al. Apr 1990 A
4917698 Carpentier et al. Apr 1990 A
4935030 Alonso Jun 1990 A
4960424 Grooters Oct 1990 A
4993428 Arms Feb 1991 A
4994077 Dobben Feb 1991 A
5002567 Bona et al. Mar 1991 A
5010892 Colvin et al. Apr 1991 A
5032128 Alonso Jul 1991 A
5035709 Wieting et al. Jul 1991 A
5037434 Lane Aug 1991 A
5071431 Sauter et al. Dec 1991 A
5104406 Curcio et al. Apr 1992 A
5147391 Lane Sep 1992 A
5163953 Vince Nov 1992 A
5163954 Curcio et al. Nov 1992 A
5163955 Love et al. Nov 1992 A
5178633 Peters Jan 1993 A
5192303 Gatturna Mar 1993 A
5258023 Reger Nov 1993 A
5316016 Adams et al. May 1994 A
5326370 Love et al. Jul 1994 A
5326371 Love et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5370685 Stevens Dec 1994 A
5376112 Duran Dec 1994 A
5396887 Imran Mar 1995 A
5397346 Walker et al. Mar 1995 A
5397348 Campbell et al. Mar 1995 A
5397351 Pavcnik et al. Mar 1995 A
5406857 Eberhardt et al. Apr 1995 A
5423887 Love et al. Jun 1995 A
5425741 Lemp et al. Jun 1995 A
5431676 Dubrul et al. Jul 1995 A
5449384 Johnson Sep 1995 A
5449385 Religa et al. Sep 1995 A
5469868 Reger Nov 1995 A
5476510 Eberhardt et al. Dec 1995 A
5488789 Religa et al. Feb 1996 A
5489297 Duran Feb 1996 A
5489298 Love et al. Feb 1996 A
5500016 Fisher Mar 1996 A
5531784 Love et al. Jul 1996 A
5533515 Coller et al. Jul 1996 A
5549665 Vesely et al. Aug 1996 A
5549666 Hata et al. Aug 1996 A
5562729 Purdy et al. Oct 1996 A
5571175 Vanney Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5573007 Bobo, Sr. Nov 1996 A
5573543 Akopov et al. Nov 1996 A
5578076 Krueger et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5607470 Milo Mar 1997 A
5613982 Goldstein Mar 1997 A
5618307 Donlon et al. Apr 1997 A
5626607 Malecki et al. May 1997 A
5628789 Vanney et al. May 1997 A
5662704 Gross Sep 1997 A
5669917 Sauer Sep 1997 A
5693090 Unsworth et al. Dec 1997 A
5695503 Krueger et al. Dec 1997 A
5713952 Vanney et al. Feb 1998 A
5713953 Vallana et al. Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5716399 Love Feb 1998 A
5720755 Dakov Feb 1998 A
5725554 Simon Mar 1998 A
5728064 Burns et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735894 Krueger et al. Apr 1998 A
5752522 Murphy May 1998 A
5755782 Love et al. May 1998 A
5766240 Johnson Jun 1998 A
5776187 Krueger et al. Jul 1998 A
5776188 Shepherd et al. Jul 1998 A
5800527 Jansen et al. Sep 1998 A
5807405 Vanney et al. Sep 1998 A
5814097 Sterman et al. Sep 1998 A
5814098 Hinnenkamp et al. Sep 1998 A
5814100 Carpentier et al. Sep 1998 A
5824060 Christie et al. Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5830239 Toomes Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5843179 Vanney et al. Dec 1998 A
5848969 Panescu et al. Dec 1998 A
5855563 Kaplan et al. Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855603 Reif Jan 1999 A
5860992 Daniel Jan 1999 A
5861028 Angell Jan 1999 A
5865801 Houser Feb 1999 A
5876436 Vanney et al. Mar 1999 A
5879371 Gardiner et al. Mar 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5891195 Klostermeyer et al. Apr 1999 A
5895420 Mirsch, II et al. Apr 1999 A
5902308 Murphy May 1999 A
5908450 Gross et al. Jun 1999 A
5908452 Bokros et al. Jun 1999 A
5910170 Reimink et al. Jun 1999 A
5919147 Jain Jul 1999 A
5921934 Teo Jul 1999 A
5921935 Hickey Jul 1999 A
5924984 Rao Jul 1999 A
5931969 Carpentier et al. Aug 1999 A
5935163 Gabbay Aug 1999 A
5957949 Leonhardt et al. Sep 1999 A
5961549 Nguyen et al. Oct 1999 A
5961550 Carpentier et al. Oct 1999 A
5972004 Williamson, IV et al. Oct 1999 A
5972024 Northrup, III et al. Oct 1999 A
5976183 Ritz Nov 1999 A
5984949 Levin Nov 1999 A
5984959 Robertson et al. Nov 1999 A
5984973 Girard et al. Nov 1999 A
6007577 Vanney et al. Dec 1999 A
6010531 Donlon et al. Jan 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6045576 Starr et al. Apr 2000 A
6059827 Fenton, Jr. May 2000 A
6066160 Colvin et al. May 2000 A
6068657 Lapeyre et al. May 2000 A
6074041 Imanaka et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6074418 Buchanan et al. Jun 2000 A
6081737 Shah Jun 2000 A
6083179 Oredsson Jul 2000 A
6096074 Pedros Aug 2000 A
6099475 Seward et al. Aug 2000 A
6102944 Huynh Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6113632 Reif Sep 2000 A
6117091 Young et al. Sep 2000 A
6126007 Kari et al. Oct 2000 A
6129758 Love Oct 2000 A
6139575 Shu et al. Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6143025 Stobie et al. Nov 2000 A
6149658 Gardiner et al. Nov 2000 A
6162233 Williamson, IV et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6168614 Anderson et al. Jan 2001 B1
6176877 Buchanan et al. Jan 2001 B1
6183512 Howanec, Jr. et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6197054 Hamblin, Jr. et al. Mar 2001 B1
6200306 Klostermeyer Mar 2001 B1
6203553 Robertson Mar 2001 B1
6214043 Krueger et al. Apr 2001 B1
6217610 Carpentier et al. Apr 2001 B1
6217611 Klostermeyer Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6231602 Carpentier et al. May 2001 B1
6241765 Griffin et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6245105 Nguyen et al. Jun 2001 B1
6254636 Peredo Jul 2001 B1
6264691 Gabbay Jul 2001 B1
6270526 Cox Aug 2001 B1
6270527 Campbell et al. Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6283995 Moe et al. Sep 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6299638 Sauter Oct 2001 B1
6309417 Spence Oct 2001 B1
6312447 Grimes Nov 2001 B1
6312465 Griffin et al. Nov 2001 B1
6319280 Schoon Nov 2001 B1
6319281 Patel Nov 2001 B1
6322588 Ogle et al. Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6328763 Love et al. Dec 2001 B1
6338740 Carpentier Jan 2002 B1
6350281 Rhee Feb 2002 B1
6358278 Brendzel et al. Mar 2002 B1
6358556 Ding et al. Mar 2002 B1
6371983 Lane Apr 2002 B1
6391053 Brendzel et al. May 2002 B1
6395025 Fordenbacher et al. May 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6409759 Peredo Jun 2002 B1
6413275 Nguyen et al. Jul 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6425902 Love Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6447524 Knodel Sep 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468305 Otte Oct 2002 B1
6503272 Duerig et al. Jan 2003 B2
6514265 Ho et al. Feb 2003 B2
6530952 Vesely Mar 2003 B2
6547827 Carpentier et al. Apr 2003 B2
6551332 Nguyen et al. Apr 2003 B1
6558418 Carpentier et al. May 2003 B2
6569196 Vesely May 2003 B1
6582462 Andersen et al. Jun 2003 B1
6585766 Huynh et al. Jul 2003 B1
6589279 Anderson et al. Jul 2003 B1
6598307 Love et al. Jul 2003 B2
6602289 Colvin et al. Aug 2003 B1
6607541 Gardiner et al. Aug 2003 B1
6613059 Ho et al. Sep 2003 B2
6613085 Anderson et al. Sep 2003 B1
6641593 Schaller et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6676671 Robertson et al. Jan 2004 B2
6678962 Love et al. Jan 2004 B1
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6695859 Golden et al. Feb 2004 B1
6709457 Otte et al. Mar 2004 B1
6716243 Colvin et al. Apr 2004 B1
6716244 Klaco Apr 2004 B2
6716789 Heineke et al. Apr 2004 B1
6719790 Brendzel et al. Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6764508 Roehe et al. Jul 2004 B1
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6776785 Yencho Aug 2004 B1
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6805711 Quijano et al. Oct 2004 B2
6830585 Artof et al. Dec 2004 B1
6833924 Love et al. Dec 2004 B2
6837902 Nguyen et al. Jan 2005 B2
6846324 Stobie Jan 2005 B2
6846325 Liddicoat Jan 2005 B2
6872226 Cali et al. Mar 2005 B2
6893459 Macoviak May 2005 B1
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908481 Cribier Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6913607 Ainsworth et al. Jul 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6921407 Nguyen et al. Jul 2005 B2
6926730 Nguyen et al. Aug 2005 B1
6929653 Streeter Aug 2005 B2
6939365 Fogarty Sep 2005 B1
6945980 Nguyen et al. Sep 2005 B2
6945997 Huynh et al. Sep 2005 B2
6960221 Ho et al. Nov 2005 B2
6974476 McGuckin et al. Dec 2005 B2
7011681 Vesely Mar 2006 B2
7025780 Gabbay Apr 2006 B2
7037333 Myers et al. May 2006 B2
7070616 Majercak et al. Jul 2006 B2
7083648 Yu Aug 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7137184 Schreck Nov 2006 B2
7141064 Scott et al. Nov 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7172625 Shu et al. Feb 2007 B2
7175659 Hill et al. Feb 2007 B2
7182769 Ainsworth et al. Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7201771 Lane Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7214344 Carpentier et al. May 2007 B2
7238200 Lee et al. Jul 2007 B2
7252682 Seguin Aug 2007 B2
7261732 Justino Aug 2007 B2
7300463 Liddicoat Nov 2007 B2
RE40377 Williamson, IV et al. Jun 2008 E
7393360 Spenser et al. Jul 2008 B2
7422603 Lane Sep 2008 B2
7445632 McGuckin et al. Nov 2008 B2
7513909 Lane et al. Apr 2009 B2
7547313 Gardiner et al. Jun 2009 B2
7556647 Drews et al. Jul 2009 B2
7578843 Shu Aug 2009 B2
7597711 Drews et al. Oct 2009 B2
7708775 Rowe et al. May 2010 B2
7722643 Ho et al. May 2010 B2
7744611 Nguyen et al. Jun 2010 B2
7763040 Schaller et al. Jul 2010 B2
7771469 Liddicoat et al. Aug 2010 B2
7803184 McGuckin et al. Sep 2010 B2
20010007956 Letac et al. Jul 2001 A1
20010018592 Schaller et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020026238 Lane et al. Feb 2002 A1
20020032481 Gabbay Mar 2002 A1
20020055774 Liddicoat May 2002 A1
20020058994 Hill et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020077555 Schwartz Jun 2002 A1
20020077698 Peredo Jun 2002 A1
20020091441 Guzik Jul 2002 A1
20020116054 Lundell et al. Aug 2002 A1
20020123802 Snyders Sep 2002 A1
20020128684 Foerster Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020173842 Buchanan Nov 2002 A1
20020177223 Ogle et al. Nov 2002 A1
20020183834 Klaco Dec 2002 A1
20020188348 DiMatteo et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023302 Moe et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030045902 Weadeock Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030109922 Peterson Jun 2003 A1
20030109924 Cribier Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030125793 Vesely Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030149477 Gabbay Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030167089 Lane Sep 2003 A1
20030191481 Nguyen et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030229394 Ogle et al. Dec 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20040015232 Shu Jan 2004 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040024452 Kruse et al. Feb 2004 A1
20040030381 Shu Feb 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040044406 Woolfson Mar 2004 A1
20040050393 Golden et al. Mar 2004 A1
20040068276 Golden et al. Apr 2004 A1
20040078074 Anderson et al. Apr 2004 A1
20040093075 Kuehne May 2004 A1
20040102797 Golden et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040122514 Fogarty Jun 2004 A1
20040122516 Fogarty Jun 2004 A1
20040122526 Imran Jun 2004 A1
20040167573 Williamson, IV et al. Aug 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040176839 Huynh et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040199176 Berreklouw Oct 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210305 Shu Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040225355 Stevens Nov 2004 A1
20040225356 Frater Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043760 Fogarty Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050060029 Le et al. Mar 2005 A1
20050065594 DiMatteo et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050065614 Stinson Mar 2005 A1
20050070924 Schaller et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075659 Realyvasquez et al. Apr 2005 A1
20050075667 Ho et al. Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050075730 Myers et al. Apr 2005 A1
20050080454 Drews Apr 2005 A1
20050096738 Cali et al. May 2005 A1
20050098547 Cali et al. May 2005 A1
20050101975 Nguyen et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050131429 Ho et al. Jun 2005 A1
20050137682 Justino Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050150775 Zhang et al. Jul 2005 A1
20050159811 Lane Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050165479 Drews et al. Jul 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050182486 Gabbay Aug 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240259 Sisken et al. Oct 2005 A1
20050240263 Fogarty Oct 2005 A1
20050251252 Stobie Nov 2005 A1
20050261765 Liddicoat Nov 2005 A1
20050283231 Haug et al. Dec 2005 A1
20060004389 Nguyen et al. Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060095125 Chinn et al. May 2006 A1
20060122634 Ino Jun 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060136052 Vesely Jun 2006 A1
20060136054 Berg et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060149367 Sieracki Jul 2006 A1
20060154230 Cunanan Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060195184 Lane Aug 2006 A1
20060195185 Lane Aug 2006 A1
20060195186 Drews Aug 2006 A1
20060207031 Cunanan et al. Sep 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060235508 Lane Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060246888 Bender et al. Nov 2006 A1
20060253191 Salahieh et al. Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271172 Tehrani Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276888 Lee Dec 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070010835 Breton et al. Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070016285 Lane Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016288 Gurskis Jan 2007 A1
20070027461 Gardiner et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070078509 Lotfy Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070095698 Cambron May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070106313 Golden et al. May 2007 A1
20070129794 Realyvasquez Jun 2007 A1
20070142848 Ainsworth et al. Jun 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070150053 Gurskis Jun 2007 A1
20070156233 Kapadia et al. Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070179604 Lane Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070225801 Drews et al. Sep 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070255398 Yang et al. Nov 2007 A1
20070260305 Drews et al. Nov 2007 A1
20070265701 Gurskis et al. Nov 2007 A1
20070270944 Bergheim et al. Nov 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20080004696 Vesely Jan 2008 A1
20080033543 Gurskis et al. Feb 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080097595 Gabbay Apr 2008 A1
20080119875 Ino et al. May 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080319543 Lane Dec 2008 A1
20090036903 Ino et al. Feb 2009 A1
20090112233 Xiao Apr 2009 A1
20090192599 Lane et al. Jul 2009 A1
20090192602 Kuehn Jul 2009 A1
20090192603 Ryan Jul 2009 A1
20090192604 Gloss Jul 2009 A1
20090192605 Gloss et al. Jul 2009 A1
20090192606 Gloss et al. Jul 2009 A1
20090210052 Forster et al. Aug 2009 A1
20090264903 Lee et al. Oct 2009 A1
20090319038 Gurskis et al. Dec 2009 A1
20100030244 Woolfson et al. Feb 2010 A1
20100044410 Argentine et al. Feb 2010 A1
20100100174 Gurskis Apr 2010 A1
20100249894 Oba et al. Sep 2010 A1
Foreign Referenced Citations (65)
Number Date Country
2356656 Jan 2000 CN
19532973 Nov 1996 DE
0 084 395 Aug 1986 EP
0 096 721 Dec 1987 EP
0 125 393 Dec 1987 EP
0 179 562 Jul 1989 EP
0 826 340 Mar 1998 EP
1057460 Dec 2000 EP
1 088 529 Apr 2001 EP
1171059 Jan 2002 EP
971 650 Jan 2005 EP
171 059 Feb 2005 EP
1093599 Dec 1967 GB
1477643 Jun 1977 GB
2011259 Jul 1979 GB
2 056 023 Mar 1981 GB
2 069 843 Sep 1981 GB
2254254 Oct 1992 GB
2 279 134 Dec 1994 GB
1116573 Jul 1985 SU
8705489 Sep 1987 WO
8900084 Feb 1989 WO
9115167 Oct 1991 WO
9201269 Aug 1992 WO
9213502 Aug 1992 WO
9219184 Nov 1992 WO
9219185 Nov 1992 WO
9517139 Jun 1995 WO
9528899 Nov 1995 WO
9640006 Dec 1996 WO
9709933 Mar 1997 WO
9709944 Mar 1997 WO
9727799 Aug 1997 WO
9728745 Aug 1997 WO
9739688 Oct 1997 WO
9741801 Nov 1997 WO
9742871 Nov 1997 WO
9806329 Feb 1998 WO
9911201 Mar 1999 WO
9915112 Apr 1999 WO
9951169 Oct 1999 WO
0032105 Jun 2000 WO
0040176 Jul 2000 WO
0044311 Aug 2000 WO
0056250 Sep 2000 WO
0059382 Oct 2000 WO
0060995 Oct 2000 WO
0064380 Nov 2000 WO
0110310 Feb 2001 WO
0110312 Feb 2001 WO
0149217 Jul 2001 WO
0158363 Aug 2001 WO
0176510 Oct 2001 WO
0182840 Nov 2001 WO
0187190 Nov 2001 WO
03053289 Jul 2003 WO
03063740 Aug 2003 WO
2004006810 Jan 2004 WO
2004089246 Oct 2004 WO
2005004753 Jan 2005 WO
2005020842 Mar 2005 WO
2005039452 May 2005 WO
2005072655 Aug 2005 WO
2006086135 Aug 2006 WO
2009137517 Nov 2009 WO
Non-Patent Literature Citations (2)
Entry
Lutter, et al., Percutaneous Valve Replacement: Current State and Future Prospects; Ann. Thorac. Surg. 2004;78:2199-2206.
Jansen, et al., “Detachable Shape-Memory Sewing Ring for Heart Valves,” Artif. Organs.—vol. 16, No. 3, 1992, pp. 294-297, Helmholtz Institute for Biomedical Engineering, Technical University of Aachen, Aachn, Germany.
Related Publications (1)
Number Date Country
20100010616 A1 Jan 2010 US
Continuations (1)
Number Date Country
Parent 10681700 Oct 2003 US
Child 12498195 US